Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib

Completed

Conditions studied: Carcinoma, Hepatocellular

In brief

In this international non-interventional study safety and clinical data concerning the treatment of patients suffering from Hepatocellular Carcinoma (HCC) will be collected.

Key facts

Study ID

NCT00812175

Run by

Bayer

People needed

3371

Starts

2009-01-01

Expected to finish

2012-04-01

Last updated by the study team

2016-10-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Outpatients with histologically/cytologically documented or radiographically diagnosed unresectable HCC who are candidates for systemic therapy and for whom a decision to treat with Nexavar has been made. Radiographic diagnosis HCC NIS, needs typical findings of HCC by radiographic method i.e. on multi-dimensional, dynamic CT, CT hepatic arteriography (CTHA)/CT arterial portography (CTAP), or MRI.
• Patients must have signed an informed consent form
• Patients must have a life expectancy of at least 8 weeks

You may not qualify if…

• Exclusion criteria must follow the approved local product information

Where it is running

• Study site — Many Locations, Arizona, United States
• Study site — Many Locations, Arkansas, United States
• Study site — Many Locations, California, United States
• Study site — Many Locations, Colorado, United States
• Study site — Many Locations, Connecticut, United States
• Study site — Many Locations, Florida, United States
• Study site — Many Locations, Georgia, United States
• Study site — Many Locations, Hawaii, United States
• Study site — Many Locations, Illinois, United States
• Study site — Many Locations, Indiana, United States
• Study site — Many Locations, Iowa, United States
• Study site — Many Locations, Kansas, United States
• Study site — Many Locations, Kentucky, United States
• Study site — Many Locations, Louisiana, United States
• Study site — Many Locations, Maryland, United States
• Study site — Many Locations, Massachusetts, United States
• Study site — Many Locations, Michigan, United States
• Study site — Many Locations, Minnesota, United States
• Study site — Many Locations, Missouri, United States
• Study site — Many Locations, Nebraska, United States
• Study site — Many Locations, Nevada, United States
• Study site — Many Locations, New Hampshire, United States
• Study site — Many Locations, New Jersey, United States
• Study site — Many Locations, New York, United States
• Study site — Many Locations, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.